I assume this includes the 5 patients reported on in Jan, before the trial was expanded. So an additional 10 patients enrolled over the past 10 months or so.
Ann: Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.020(4.76%) |
Mkt cap ! $115.6M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 40.0¢ | $4.068K | 10.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 668 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 4783 | 7 |
View Market Depth
| Last trade - 11.01am 29/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |